Alyftrek Tablet, Film Coated
Product Images NDC 51167-121

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Alyftrek (NDC 51167-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Alyftrek 01)

Chemical structure of the active ingredients vanzacaftor, tezacaftor, and deutivacaftor, showing complex molecular components including a calcium ion (Ca2+) and two molecules of water (2 H2O).*

FDA Label Image

Chemical Structure (Alyftrek 02)

Chemical structure of vanzacaftor, tezacaftor, and deutivacaftor shown in a molecular diagram highlighting atomic connections and specific functional groups.*

FDA Label Image

Chemical Structure (Alyftrek 03)

Chemical structure diagram of the active ingredient vanzacaftor from the drug ALYFTREK, showing its molecular formula including aromatic rings, hydroxyl group, amide bonds, and deuterated methyl groups.*

FDA Label Image

Principal Display Panel (4 mg/20 mg/50 mg Blister Pack Carton)

Packaging label for ALYFTREK tablets, containing vanzacaftor, tezacaftor, and deutivacaftor. Each film-coated oral tablet has strengths of 4 mg/20 mg/50 mg. The label indicates a supply of 84 tablets in 4 wallets, each containing 21 tablets, manufactured by Vertex Pharmaceuticals Incorporated. The label includes dosage instructions and storage information.*

FDA Label Image

Principal Display Panel (10 mg/50 mg/125 mg Blister Pack Carton)

Packaging label for ALYFTREK tablets containing vanzacaftor, tezacaftor, and deutivacaftor. Each film-coated tablet is dosed at 10 mg/50 mg/125 mg. The label shows the product name, dosage strength, and that the package contains 56 tablets divided into 4 wallets of 14 tablets each. Manufactured by Vertex Pharmaceuticals Incorporated, the label includes storage instructions, usage directions, and a note for pharmacists to dispense the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.